Statera BioPharma Inc (STAB): "In a separate, parallel initiative, we...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	58
Posts	2450
Boards Moderated	0
Alias Born	07/27/2010

CalderQuacks

Re: None

Wednesday, 08/12/2015 4:01:42 PM

Wednesday, August 12, 2015 4:01:42 PM

"In a separate, parallel initiative, we continue our negotiations with the Department of Defense regarding two proposals supporting additional studies in animals and in humans. These studies are not required for obtaining pre-EUA status, but can support further advancement of entolimod development to full licensure for filing of a biologics license application, or BLA. These proposals have a combined grant amount of approximately $15 million and have been recommended for funding by peer reviewers as was disclosed in our
prior press releases.

While some of these negotiations have been ongoing for several months, it is our understanding that the program funding for these proposals needs to be allocated by September 30, 2015, the end of the government’s fiscal year." -Dr. Yakov Kogan –CEO

http://cdn.irdirect.net/IR/675/1435/2Q15%20Investor%20Call%20Transcript%208-12-15.pdf